Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Reprod Dev ; 66(6): 587-592, 2020 Dec 22.
Article in English | MEDLINE | ID: mdl-32830151

ABSTRACT

We investigated the effects of long-term repeated treatments with a sustainable gonadotropin-releasing hormone (GnRH) antagonist, degarelix acetate, on testicular hormonal secretion, size, ultrasound images, histology and spermatogenesis in goats to assess its efficacy as a chemical castration method. Male Shiba goats (3-6 months of age) were treated subcutaneously with degarelix acetate every 4 weeks for 24 weeks. Plasma testosterone and insulin-like peptide 3 concentrations decreased (P < 0.05) within 2 days after the first treatment and remained low until 29 weeks (P < 0.05). Scrotal circumference and testicular pixel intensity were lower from 2-6 months and from 1-6 months, respectively, compared to the pretreatment values (P < 0.05). The testis and epididymis weights were lower at 24 weeks compared to those in untreated goats (P < 0.05). There were no sperm in the seminiferous tubules of testicular tissue sections or in homogenates of the epididymis at 24 weeks. These results suggest that repeated treatment with degarelix acetate is an effective chemical castration method for goats.


Subject(s)
Gonadotropin-Releasing Hormone/antagonists & inhibitors , Oligopeptides/administration & dosage , Testis/drug effects , Animals , Epididymis/drug effects , Epididymis/metabolism , Goats , Immunoassay , Limit of Detection , Luteinizing Hormone/blood , Male , Nerve Tissue Proteins/blood , Orchiectomy , Scrotum , Seminiferous Tubules/metabolism , Spermatogenesis/drug effects , Spermatozoa/physiology , Testis/diagnostic imaging , Testis/metabolism , Testosterone/blood , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...